BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16403830)

  • 21. [SAPHO syndrome and aseptic osteitis].
    Cotten A; Boutry N; Demondion X; Chastanet P; Flipo RM
    Ann Radiol (Paris); 1997; 40(3):189-96. PubMed ID: 9810077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome complicated by seven pulmonary emboli in a 15-year old patient.
    Coloe J; Diamantis S; Henderson F; Morrell DS
    J Am Acad Dermatol; 2010 Feb; 62(2):333-6. PubMed ID: 20115954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of pediatric synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the first Chinese case series from a single center.
    Wu N; Shao Y; Huo J; Zhang Y; Cao Y; Jing H; Zhang F; Yu C; Yu Y; Li C; Song H; Zhang W
    Clin Rheumatol; 2021 Apr; 40(4):1487-1495. PubMed ID: 32929648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects.
    Colina M; Govoni M; Orzincolo C; Trotta F
    Arthritis Rheum; 2009 Jun; 61(6):813-21. PubMed ID: 19479702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical skin lesions induced by anti-TNF-α agents in SAPHO syndrome.
    Li C; Wu X; Cao Y; Zeng Y; Zhang W; Zhang S; Liu Y; Jin H; Zhang W; Li L
    Clin Rheumatol; 2019 Jan; 38(1):53-61. PubMed ID: 29611085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cases of synovitis, acne, pustulosis, osteitis--SAPHO syndrome.
    Spyridonidis T; Giannakenas C; Papandrianos N; Barla P; Apostolopoulos DJ
    Hell J Nucl Med; 2007; 10(2):109-12. PubMed ID: 17684587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R; Loza E; Jover JA; Benitez Del Castillo JM; Mendez R; Hernandez-Garcia C; Pato E
    Scand J Rheumatol; 2009; 38(1):58-62. PubMed ID: 18991187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease.
    Fiorino G; Allez M; Malesci A; Danese S
    Aliment Pharmacol Ther; 2009 May; 29(9):921-7. PubMed ID: 19210297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperostosis and osteitis in Sapho syndrome: conservative or surgical treatment.
    Bianchi G; Marinelli A; Frizziero A; Mercuri M
    Chir Organi Mov; 2004; 89(1):45-9. PubMed ID: 15382585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial.
    Wang L; Gong L; Zhang X; Cao Y; Long P; Zhang W; Zeng X; Li C
    Clin Rheumatol; 2021 Jun; 40(6):2427-2438. PubMed ID: 33389313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The SAPHO syndrome: a study of 16 cases].
    Olivé A; Pérez-Andrés R; Rivas A; Holgado S; Casado E; Gumá M; Tena X
    Med Clin (Barc); 1999 Jan; 112(2):61-3. PubMed ID: 10065433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage.
    Deutschmann A; Mache CJ; Bodo K; Zebedin D; Ring E
    Pediatrics; 2005 Nov; 116(5):1231-3. PubMed ID: 16264014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates.
    Just A; Adams S; Brinkmeier T; Barsegian V; Lorenzen J; Schilling F; Frosch P
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):657-60. PubMed ID: 18266863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The SAPHO syndrome or psoriatic arthritis: a complicated differential diagnosis. Apropos 3 cases].
    Sanjuán Portugal F; Manero Ruiz FJ; Figueras Villalba P; Martínez Alvarez R
    Rev Clin Esp; 1995 Apr; 195(4):233-6. PubMed ID: 7784657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [SAPHO syndrome: common denominator for various bone and skin diseases].
    Jahangier ZN; Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):764-9. PubMed ID: 9213797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome.
    Wagner AD; Andresen J; Jendro MC; Hülsemann JL; Zeidler H
    Arthritis Rheum; 2002 Jul; 46(7):1965-8. PubMed ID: 12124882
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of resistant SAPHO syndrome with anti-TNF therapy.
    Hampton SL; Youssef H
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23355559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SAPHO syndrome.
    Kahn MF; Chamot AM
    Rheum Dis Clin North Am; 1992 Feb; 18(1):225-46. PubMed ID: 1532859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.